X
https://www.contractpharma.com/contents/view_breaking-news/2023-05-02/fda-approves-recipharm-site-for-manufacture-of-vowst/9769
https://www.recipharm.com/press-releases/arranta-bio-recipharm-company-signs-contract-mit-develop-rapid-manufacturing-mrna-therapeutics#:~:text=Arranta%20Bio%2C%20part%20of%20Recipharm\'s,manufacturing%20technology%20for%20mRNA%20therapeutics.
https://www.contractpharma.com/contents/view_breaking-news/2023-04-05/recipharm-names-joaquim-mascaro-cfo/?widget=listSection
https://www.recipharm.com/press-releases/recipharms-arranta-bio-expands-rna-process-development-capacity-50-cent-meet-increased-customer-demand
https://www.contractpharma.com/contents/view_breaking-news/2023-03-09/arranta-bio-expands-rna-process-development-capacity-by-50/?widget=listSection
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-recipharm-monts-59598.pdf
https://www.contractpharma.com/contents/view_breaking-news/2022-11-30/recipharm-invests-in-single-dose-nasal-platform-capabilities/?widget=listSection
https://www.contractpharma.com/contents/view_breaking-news/2022-11-02/recipharm-strengthens-pre-filled-syringe-and-cartridge-offering/9769
https://www.contractpharma.com/contents/view_breaking-news/2022-10-26/recipharm-invests-in-lab-technology-at-kaysersberg-facility/
Market Place
Share 
